ArticleAnnals of translational medicine2020
Methylation of the
Article in Annals of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 6 citations in OpenAlex.
- Deciphering key chemotherapeutic drug targets within tyrosine metabolism for breast cancer and advancing a wide-ranging diagnostic strategy.Discover oncology · 2025Article
- Crossing the "Birth Border" for Epigenetic Effects.Biological psychiatry · 2022Article
- Characteristics of global retractions of schizophrenia-related publications: A bibliometric analysis.Frontiers in psychiatry · 2022Article
- Retraction "Annals of translational medicine · 2020Article
Corrections and comments
- Retraction · 2020-11-01Concerns/Issues about Data ·
- RetractedRetraction "2020
Authors and funding
9 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEarlier studies have shown that patients with schizophrenia have abnormalities in DNA methylation. Monoamine oxidase A (
methodsThere were 151 individuals with schizophrenia (104 males and 47 females), which were diagnosed according to DSM-V, the DNA of peripheral blood of all samples was extracted and chemically modified with bisulfite. The promoter region of
resultsIn the male schizophrenia group (BM) and the male control group (DM),
conclusionsAlthough the role of gene methylation in the development of schizophrenia is still unclear, our findings suggest that DNA methylation of
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.